Delivery Order 36F79720D0180-36C25725N0376
Award Date
7/1/25
Potential Completion Date
6/30/27
Potential Value
$1.1M
Federal Agency
Veterans Integrated Service Network 17
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
East Hanover, NJ 07936, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award by the Department of Veterans Affairs (VA) to Novartis Pharmaceuticals Corporation, a large, foreign-owned pharmaceutical manufacturer. The contract is a firm fixed-price delivery order worth $736,610 for the delivery of the cancer treatment drug PLUVICTO. The contract utilizes the VA's Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) and has an ultimate completion date of August 4, 2026. The contract does not have a small business set-aside...
This is a federal contract award from the U.S. Department of Veterans Affairs (VA) to Novartis Pharmaceuticals Corporation, a foreign-owned, for-profit manufacturer of pharmaceutical goods. The contract, valued at $231,396.00, is a Delivery Order contract with a Firm Fixed Price pricing type. The contract is for the procurement of specialized medical treatments, such as cancer therapies and advanced pharmaceuticals, to support the VA's medical programs. The contract utilizes the...
This federal contract award is for the delivery of the radiopharmaceutical PLUVICTO to the Cleveland VA Medical Center (VAMC). The $598,124.52 firm fixed price delivery order was issued against Novartis Pharmaceuticals Corporation's Federal Supply Schedule (FSS) contract for pharmaceuticals and drugs (FSS-61-IB). Novartis, a foreign-owned for-profit manufacturer, has provided specialized cancer therapies like Kymriah to VA networks and facilities under previous orders and agreements. This...
The Department of Veterans Affairs (VA) awarded a $283,526.57 delivery order to Novartis Pharmaceuticals Corporation, doing business as NPS, for emergency drug orders to support the Tennessee Valley Healthcare System (TVHS). This order was placed against Novartis' Federal Supply Schedule (FSS) 61-IB contract for pharmaceuticals and drugs, which has a total potential value of $5.4 billion and runs through August 2025. Novartis, a foreign-owned, for-profit manufacturer, has provided specialized...
This is a firm fixed-price delivery order awarded by the Department of Veterans Affairs (VA) to Novartis Pharmaceuticals Corporation (Novartis), a foreign-owned, for-profit manufacturer of pharmaceutical products. The $283,526.57 order is for Novartis' cell therapy treatment Tisagenlecleucel, which is used to treat certain types of cancer. The order was placed through Novartis' existing Federal Supply Schedule (FSS) contract for pharmaceuticals and drugs (FSS-61-IB), which allows the VA to...
This is a firm fixed-price delivery order awarded by the Department of Veterans Affairs (VA) to Novartis Pharmaceuticals Corporation, a large foreign-owned pharmaceutical manufacturer. The contract is for the drug Fabhalta 200 mg, with a ceiling value of $33,838.23 and an ultimate completion date of August 7, 2025. The contract was awarded on August 4, 2025 and does not have a set-aside designation. Novartis holds two significant federal contract vehicles with the VA - a $21.5 million Blanket...
This is a federal contract award to Advanced Accelerator Applications USA Inc., a subsidiary of Novartis, for the delivery of the radiopharmaceutical product PLUVICTO. The contract, valued at $2,979,818.10, is a delivery order awarded by the Department of Veterans Affairs (VA) under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB). The contract has an ultimate completion date of October 31, 2025. This award is not set aside for small businesses. Advanced Accelerator Applications...
This is a firm fixed-price delivery order contract awarded by the Veterans Integrated Service Network 19, a civilian agency of the U.S. government, to Novartis Vaccines and Diagnostics, Inc., a foreign-owned for-profit manufacturer. The contract, valued at $128,960.00, is for express pharmacy orders and has an ultimate completion date of September 30, 2015. The contract was not set aside for any specific business type. No details are provided about a larger contract vehicle that this order may...
This is a federal contract award to Advanced Accelerator Applications USA Inc., a foreign-owned, for-profit manufacturer of radiopharmaceuticals and nuclear medicine products. The contract is a Delivery Order under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB), with a Firm Fixed Price pricing type and a ceiling value of $398,509.58. The contract is for the supply of PLUVICTO, a radiopharmaceutical product used in cancer treatment and diagnostic imaging. The contract was...
This $2,356,913.50 federal contract was awarded by the Veterans Integrated Service Network 10 (VISN 10), a division of the U.S. Department of Veterans Affairs (VA), to Advanced Accelerator Applications USA Inc., a foreign-owned, for-profit manufacturer of radiopharmaceuticals and nuclear medicine products. The contract is for the delivery of PLUVICTO and LUTATHERA, two specialized radiopharmaceutical products used in cancer treatment and diagnostic imaging. The contract is a Delivery Order under...